ID=H0204
URL=http://www.who.int/ncd/hgn/Classification_Cystic_Fibrosis.htm
SIZE=54975
DATE=11/07/2002
TIME=17:02:36
DATASET=Biology
HTML=<html>
<head>
<title>Classification of Cystic Fibrosis and Related Disorders</title>
<meta name="DC.title" content="Classification of Cystic Fibrosis and Related Disorders">

<meta name="Microsoft Border" content="none">
<meta name="DC.publisher" content="World Health Organization">
<meta name="DC.rights" content="http://www.who.int/home/copyright">
<meta name="DC.format" content="text/html">
<meta name="who.pubdate" content="Wed Jun 19 08:37:12 2002">
<meta name="who.pubby" content="kerneng@who.int">

</head>
<body topmargin="0" leftmargin="0" vlink="#008080" alink="#FF0000">
<table border="0" width="640" style="border: ">
  <tr>
    <td width="640"><table height="1" width="631">
      <tr>
        <td rowSpan="2" vAlign="top" width="120"><a href="/"><img
        alt="World Health Organization" border="0" src="../images/whologo.jpg" width="120" height="80"></a></td>
        <td vAlign="top" width="500"><a href="/"><img
        alt="World Health Organization" border="0" src="../images/top_line.gif" width="500" height="12"></a></td>
      </tr>
      <tr>
        <td vAlign="top" width="500"><p align="right"><img src="../images/hgn.gif"
        alt="hgn.gif (8550 bytes)" width="500" height="70"></td>
      </tr>
      <tr>
        <td colSpan="2" vAlign="top" width="620"><img src="../images/blue.gif"
        alt="blue.gif (943 bytes)" align="right" width="620" height="12"></td>
      </tr>
</TBODY>
    </table>
    </td>
  </tr>
  <tr>
    <td width="620"><p align="right"><font face="Arial,Helvetica,Sans Serif" size="1">Last update:18 Jun 2002</font></td>
  </tr>
  <tr>
    <td width="620"><font face="Arial,Helvetica,Sans Serif" size="1"><p align="center"></font><font size="2"><strong>|
    <a href="/m/healthtopics-a-z/en/index.html">Health topics</a> |&nbsp; <a
    href="/">WHO home</a> | <a
    href="/site-search/data-who-hq-live/search.shtml">Search</a> | <a
    href="../ncd_sitemap.htm">Site map</a> | <a href="../contact_us.htm">Contact us</a> |</strong></font></td>
  </tr>
  <tr>
    <td width="620"><hr>
    </td>
  </tr>
  <tr>
    <td width="620"><font size="2"><p align="right"><a href="/">WHO Home </a>-&gt;
    <a href="index.htm">Human genetics</a> -&gt; <a href="publications.htm">Human genetics
    publications</a> -&gt; Classification of Cystic Fibrosis and Related Disorders<br>
    </font><br>
    </td>
  </tr>
  <tr>
    <td width="620"><div align="center"><center><table border="0" cellPadding="3"
    cellSpacing="0" width="615">
<TBODY>
      <tr>
        <td vAlign="top" width="500" height="1"><font size="2"><i>Document reference</i><span
        lang="EN-GB" style="font-size:9.0pt;mso-bidi-font-size:10.0pt">: <em>WHO/CF/HGN/00.2,&nbsp;
        </span><!--[if supportFields]><span class=manual><span lang=EN-GB
style='font-size:9.0pt;mso-bidi-font-size:10.0pt'><span style='mso-element:
field-begin'></span>PRIVATE </span></span><![endif]--><span lang="EN-GB" style="font-size:9.0pt;mso-bidi-font-size:10.0pt">ENGLISH ONLY, </span><span
        lang="EN-GB"
        style="font-size:9.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA;layout-grid-mode:line">Distr.:<span
        style="mso-spacerun: yes">&nbsp; </span>GENERAL</span></em></font><i><font SIZE="-1"> </font></i><p>&nbsp;</p>
        <p align="center"><strong>&nbsp;<font size="3" color="#8000FF">&nbsp;&nbsp;</font><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Arial;mso-bidi-font-family:"Times New Roman";font-variant:
small-caps">Classification
        of Cystic Fibrosis and Related Disorders</span></strong></p>
        <p class="MsoHeading9" align="center"><font face="Arial Black"><em><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times" font-style:normal">Report
        of a joint WHO/ICF(M)A/ECFTN meeting, <o:p></span></em></font></p>
        <i style="mso-bidi-font-style:normal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Times New Roman" mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA; layout-grid-mode:line"><b
        style="mso-bidi-font-weight:normal"><p align="center"></b><u>Stockolm, Sweden, 3 June 2000</u></span></i></td>
        <td vAlign="top" width="146" height="1" bgcolor="#eaeaf2"><table>
          <tr>
            <th bgColor="#000080"><font face="Arial,Helvetica,Sans Serif" size="2" color="#FFFF00"><strong>Human genetics
            shortcut</strong></font></th>
          </tr>
          <tr>
            <td><a href="hgn_news.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>News</em></strong></font></a></td>
          </tr>
          <tr>
            <td><a href="publications.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>Publications</em></strong></font></a></td>
          </tr>
          <tr>
            <td><a href="databases.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>Databases</em></strong></font></a></td>
          </tr>
          <tr>
            <td><a href="hgn_events.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>Events</em></strong></font></a></td>
          </tr>
          <tr>
            <td><a href="country_profiles.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>Country
            profiles</em></strong></font></a></td>
          </tr>
          <tr>
            <td><a href="glopartners.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>Global
            partners</em></strong></font></a></td>
          </tr>
          <tr>
            <td><a href="collcentres.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>Collaborating
            centres</em></strong></font></a></td>
          </tr>
          <tr>
            <td><a href="relatedsites.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>Related
            sites</em></strong></font></a></td>
          </tr>
        </table>
        </td>
      </tr>
      <tr>
        <td colSpan="2" vAlign="top" width="654" height="1"><table border="0" width="100%">
          <tr>
            <td width="100%"><table border="1" cellspacing="0" cellpadding="0"
            style="margin-left:-1.7pt;
 border-collapse:collapse;mso-table-layout-alt:fixed;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"
            width="593" bordercolor="#008080" bordercolorlight="#008080" bordercolordark="#008080">
              <tr>
                <td width="300" valign="top" style="width:240.95pt;padding:0cm 5.4pt 0cm 5.4pt"
                align="center" bordercolor="#008080" bordercolorlight="#008080" bordercolordark="#008080"><p
                class="MsoNormal" style="margin-top:4.5pt;mso-hyphenate:none;tab-stops:-36.0pt"><!--[if supportFields]><span
  lang=EN-GB><span style='mso-element:field-begin'></span>PRIVATE </span><![endif]--><!--[if supportFields]><span
  lang=EN-GB><span style='mso-element:field-end'></span></span><![endif]--><span
                lang="EN-GB" style="font-size:8.0pt;mso-bidi-font-size:10.0pt">This document is not a
                formal publication of the World Health Organization (WHO), and all rights are reserved by
                the Organization.<span style="mso-spacerun: yes">&nbsp; </span>The document may, however,
                be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not
                for sale nor for use in conjunction with commercial purposes.<o:p></o:p>&nbsp;<o:p></o:p></span></p>
                <p class="MsoNormal" style="margin-bottom:2.7pt;mso-hyphenate:none;tab-stops:
  -36.0pt"><span
                lang="EN-GB" style="font-size:8.0pt;mso-bidi-font-size:10.0pt">The views expressed in
                documents by named authors are solely the responsibility of those authors.<o:p></o:p></span></td>
                <td width="300" valign="top" style="width:240.95pt;padding:0cm 5.4pt 0cm 5.4pt"
                align="center"><p class="MsoNormal"
                style="margin-top:4.5pt;mso-hyphenate:none;tab-stops:-36.0pt"><span lang="FR"
                style="font-size:8.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:
  FR">Ce document
                n'est pas une publication officielle de l'Organisation mondiale de la Santé (OMS) et tous
                les droits y afférents sont réservés par l'Organisation.<span style="mso-spacerun: yes">&nbsp;
                </span>S'il peut être commenté, résumé, reproduit ou traduit, partiellement ou en
                totalité, il ne saurait cependant l'être pour la vente ou à des fins commerciales.<o:p></o:p></span></p>
                <p class="MsoNormal" style="margin-bottom:2.7pt;mso-hyphenate:none;tab-stops:
  -36.0pt"><span
                lang="FR" style="font-size:8.0pt;mso-bidi-font-size:10.0pt;
  mso-ansi-language:FR">Les
                opinions exprimées dans les documents par des auteurs cités nommément n'engagent que
                lesdits auteurs.<o:p></o:p></span></td>
              </tr>
            </table>
            </td>
          </tr>
        </table>
        <p><font size="3"><strong><span lang="EN-US"
        style="font-size:20.0pt;mso-bidi-font-size:10.0pt">Table of contents<o:p></span></strong></font></p>
        <p>&nbsp;</p>
        <p class="TableText"><b style="mso-bidi-font-weight:normal"><span lang="EN-US">1. <span
        style="mso-spacerun: yes">&nbsp;</span><a href="#1.&nbsp; Background">Background</a><span
        style="mso-spacerun:
  yes">&nbsp;</span></span></b></p>
        <p class="TableText"><b style="mso-bidi-font-weight:normal"><span lang="EN-US">2.<span
        style="mso-spacerun: yes">&nbsp;<a href="#2.&nbsp; The role of genotype"> </span>The role
        of genotype</a><span style="mso-spacerun: yes">&nbsp;</span></span></b></p>
        <p class="TableText"><b style="mso-bidi-font-weight:normal"><span lang="EN-US">3.<span
        style="mso-spacerun: yes">&nbsp; </span><a
        href="#3.&nbsp; The diagnosis of Cystic Fibrosis">The diagnosis of Cystic Fibrosis<span
        style="mso-spacerun: yes">&nbsp;</span></a></span></b></p>
        <p class="TableText"><b style="mso-bidi-font-weight:normal"><span lang="EN-US">4.<span
        style="mso-spacerun: yes">&nbsp; </span><a
        href="#4.&nbsp; A proposed classification for ICD-11">A proposed classification for ICD-11<span
        style="mso-spacerun: yes">&nbsp;</span></a></span></b></p>
        <p class="TableText"><b style="mso-bidi-font-weight:normal"><span lang="EN-US">5.<span
        style="mso-spacerun: yes">&nbsp; </span><a href="#5.&nbsp; List of participants">List of
        participants<span style="mso-spacerun: yes">&nbsp;</span></a></span></b></p>
        <p class="TableText"><b style="mso-bidi-font-weight:normal"><span lang="EN-US">6.<span
        style="mso-spacerun: yes">&nbsp; </span><a href="#6.&nbsp; References">References</a></span></b></p>
        <h2><a name="_Toc505740992"></a><a name="_Toc505741644"></a><a name="1.&nbsp; Background"><span
        style="mso-bookmark:_Toc505741644"><span style="mso-bookmark:_Toc505740992"><span
        lang="EN-US">1.<span style="mso-spacerun: yes">&nbsp; </span>Background</span></span></span></a></h2>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><span
        lang="EN-US">Making a diagnosis of Cystic Fibrosis (CF) is not always simple.<sup>1</sup>
        Initially, CF was recognized as a clinical syndrome. Many diagnostic problems were
        resolved by the development of the sweat test in 1950.<sup>2</sup> The test remains
        clinically reliable for most cases,<sup>3</sup> but the occasional occurrence of
        false-negative and false-positive results has always been recognized. With the cloning of
        the gene for the CF transmembrane conductance regulator(CFTR)<sup>4,5 </sup>in 1989
        clinicians hoped that genetic testing for CF would be both sensitive and specific.
        However, the more than 900 mutations so far identified in the CFTR gene have made genetic
        testing for CF difficult to develop, and making a definitive diagnosis in atypical cases
        has become sometimes more, rather than less, difficult.</span></p>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><span
        lang="EN-US">Although the rarity of most mutations has made it possible to screen by using
        a panel of 70 mutations with a sensitivity approaching 90% in the general population of
        the United States,<sup>6</sup> the complexity of the problem has been increased by
        recognition that some conditions caused by mutations in the CFTR gene fall short of the
        criteria necessary for a diagnosis of cystic fibrosis. For example, male infertility due
        to congenital bilateral absence of the vas deferens,<sup>7,8</sup> with or without mild
        sinopulmonary disease, is commonly associated with CFTR mutations. Recently it has been
        shown that unilateral vas deferens atresia may also be related to CFTR mutations.<sup>9 </sup>Recurrent
        or chronic pancreatitis is another condition where a diagnosis of CF is not appropriate,
        but in which CFTR mutations are frequently identified. These disorders are not CF but are
        CFTR-related.</span></p>
        <h2><a name="_Toc505740993"></a><a name="_Toc505741645"></a><a
        name="2.&nbsp; The role of genotype"><span style="mso-bookmark:_Toc505741645"><span
        style="mso-bookmark:_Toc505740993"><span lang="EN-US">2.<span style="mso-spacerun: yes">&nbsp;
        </span>The role of genotype</span></span></span></a></h2>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><span
        lang="EN-US">Genotype-phenotype correlation has proved to be inconsistent even for those
        specific mutations shown to be associated with "classical" cystic fibrosis.
        Among patients homozygous for the common deltaF508 mutation, and even within families, a
        variety of different clinical phenotypes and degrees of severity can be observed.<sup>10</sup>
        Occasional individuals carrying two "severe" mutations may have no clinical
        evidence of disease, at least in early life and may remain asymptomatic into the 5<sup>th</sup>
        decade (Warwick W, personal communication). Others, with typical CF features, may have no
        identifiable mutations even when their CFTR genes have been sequenced (Tsui, unpublished).
        This suggests that in addition to environmental factors, at least one gene at another
        locus (and probably more) may significantly affect the clinical picture.<sup>11 </sup>It
        further indicates that genotype alone is an insufficient basis for the classification of
        clinical syndromes associated with cystic fibrosis or the CFTR gene.</span></p>
        <h2><a name="_Toc505740994"></a><a name="_Toc505741646"></a><a
        name="3.&nbsp; The diagnosis of Cystic Fibrosis"><span style="mso-bookmark:_Toc505741646"><span
        style="mso-bookmark:_Toc505740994"><span lang="EN-US">3.<span style="mso-spacerun: yes">&nbsp;
        </span>The diagnosis of Cystic Fibrosis</span></span></span></a></h2>
        <p class="MsoNormal"><span lang="EN-US">Features suggesting or confirming the diagnosis of
        CF have recently been summarized in the U.S. Consensus document 1998 (Table).<sup>12</sup>
        This statement serves well as a reference point for the majority of cases, but it does not
        take into account the fact that approximately 5% of otherwise typical (if usually mild) CF
        individuals have negative sweat tests, and the alternative tests based on nasal, duodenal
        or rectal potential difference which help to resolve doubtful cases are not widely
        available.</span></p>
        <table border="0" width="100%">
          <tr>
            <td width="100%"><p class="MsoCaption"><span lang="EN-US">Table:<span
            style="mso-spacerun: yes">&nbsp; </span>Phenotypic features consistent with a diagnosis of
            CF<sup>12</sup></span></p>
            <table border="1"
            style="border-collapse:collapse;
 mso-table-layout-alt:fixed;border:none;mso-border-alt:solid windowtext .5pt;
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt">
              <tr>
                <td width="612" valign="top"
                style="width:459.0pt;border:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><p
                class="TableText"
                style="margin-top:12.0pt;margin-right:1.0cm;margin-bottom:
  6.0pt;margin-left:1.0cm;text-indent:-18.0pt;mso-list:l3 level1 lfo23;
  tab-stops:-72.0pt -36.0pt list 18.0pt"><span
                lang="EN-US">1.<span style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                </span>Chronic sinopulmonary disease manifested by:</span></p>
                <p class="ListBulletmr" align="left" style="margin-left:49.05pt;text-align:left"><span
                lang="EN-US" style="font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:
  Symbol">·<span
                style="font:7.0pt "Times New Roman""> </span></span><span lang="EN-US"
                style="font-size:11.0pt;mso-bidi-font-size:10.0pt">Persistent colonization/infection with
                typical CF pathogens including Staphylococcus&nbsp;&nbsp;&nbsp; aureus, nontypeable
                Haemophilius influenzae, mucoid and nonmucoid Pseudomonas aeruginosa, and Burkholderia
                cepacia.</span><br>
                <span lang="EN-US"
                style="font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:
  Symbol">·<span
                style="font:7.0pt "Times New Roman""> </span></span><span lang="EN-US"
                style="font-size:11.0pt;mso-bidi-font-size:10.0pt">Chronic cough and sputum production.<o:p></o:p></span></p>
                <p class="ListBulletmr" align="left" style="margin-left:49.05pt;text-align:left"><span
                lang="EN-US" style="font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:
  Symbol">·<span
                style="font:7.0pt "Times New Roman""> </span></span><span lang="EN-US"
                style="font-size:11.0pt;mso-bidi-font-size:10.0pt">Persistent chest radiograph
                abnormalities (e.g., bronchiectasis, atelectasis, infiltrates, hyperinflation).<o:p></o:p></span></p>
                <p class="ListBulletmr" align="left" style="margin-left:49.05pt;text-align:left"><span
                lang="EN-US" style="font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:
  Symbol">·<span
                style="font:7.0pt "Times New Roman""> </span></span><span lang="EN-US"
                style="font-size:11.0pt;mso-bidi-font-size:10.0pt">Airway obstruction manifested by
                wheezing and air trapping.<o:p></o:p></span></p>
                <p class="ListBulletmr" align="left" style="margin-left:49.05pt;text-align:left"><span
                lang="EN-US" style="font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:
  Symbol">·<span
                style="font:7.0pt "Times New Roman""> </span></span><span lang="EN-US"
                style="font-size:11.0pt;mso-bidi-font-size:10.0pt">Nasal polyps; radiographic or computed
                tomographic abnormalities of the paranasal sinuses.<o:p></o:p></span></p>
                <p class="ListBulletmr" align="left" style="margin-left:49.05pt;text-align:left"><span
                lang="EN-US" style="font-family:Symbol">·<span
                style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
                lang="EN-US" style="font-size:11.0pt;mso-bidi-font-size:
  10.0pt">Digital clubbing.</span></p>
                <p class="TableText"
                style="margin-top:12.0pt;margin-right:1.0cm;margin-bottom:
  6.0pt;margin-left:1.0cm;text-indent:-18.0pt;mso-list:l3 level1 lfo23;
  tab-stops:-72.0pt -36.0pt list 18.0pt"><span
                lang="EN-US">2.<span style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                </span>Gastrointestinal and nutritional abnormalities including:</span></p>
                <p class="ListBulletmr" align="left" style="margin-left:49.05pt;text-align:left"><span
                lang="EN-US" style="font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:
  Symbol">·<span
                style="font:7.0pt "Times New Roman""> </span></span><span lang="EN-US"
                style="font-size:11.0pt;mso-bidi-font-size:10.0pt">Intestinal: meconium ileus, distal
                intestinal obstruction syndrome, rectal prolapse.<o:p></o:p></span></p>
                <p class="ListBulletmr" align="left" style="margin-left:49.05pt;text-align:left"><span
                lang="EN-US" style="font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:
  Symbol">·<span
                style="font:7.0pt "Times New Roman""> </span></span><span lang="EN-US"
                style="font-size:11.0pt;mso-bidi-font-size:10.0pt">Pancreatic: pancreatic insufficiency,
                recurrent pancreatitis.<o:p></o:p></span></p>
                <p class="ListBulletmr" align="left" style="margin-left:49.05pt;text-align:left"><span
                lang="EN-US" style="font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:
  Symbol">·<span
                style="font:7.0pt "Times New Roman""> </span></span><span lang="EN-US"
                style="font-size:11.0pt;mso-bidi-font-size:10.0pt">Hepatic: chronic hepatic disease
                manifested by clinical or histologic evidence of focal biliary cirrhosis or multilobular
                cirrhosis.<o:p></o:p></span></p>
                <p class="ListBulletmr" align="left" style="margin-left:49.05pt;text-align:left"><span
                lang="EN-US" style="font-family:Symbol">·<span
                style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
                lang="EN-US" style="font-size:11.0pt;mso-bidi-font-size:
  10.0pt">Nutritional: failure
                to thrive (protein-calorie malnutrition), hypoproteinemia and edema, complications
                secondary to fat-soluble vitamin deficiency.</span></p>
                <p class="TableText"
                style="margin-top:12.0pt;margin-right:1.0cm;margin-bottom:
  6.0pt;margin-left:1.0cm;text-indent:-18.0pt;mso-list:l3 level1 lfo23;
  tab-stops:-72.0pt -36.0pt list 18.0pt"><span
                lang="EN-US">3.<span style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                </span>Salt loss syndromes: acute salt depletion, chronic metabolic alkalosis.</span></p>
                <p class="TableText"
                style="margin-top:12.0pt;margin-right:1.0cm;margin-bottom:
  6.0pt;margin-left:1.0cm;text-indent:-18.0pt;mso-list:l3 level1 lfo23;
  tab-stops:-72.0pt -36.0pt list 18.0pt"><span
                lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt">4.<span
                style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
                lang="EN-US">Male urogenital abnormalities resulting in obstructive azoospermia (CBAVD). </span><span
                lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt"><o:p></o:p></span></td>
              </tr>
            </table>
            </td>
          </tr>
        </table>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><span
        lang="EN-US"><br>
        Another recent approach has been to regard individuals with a CF genotype but no
        discernable clinical disease (e.g. some infants detected by neonatal screening) as
        "pre-CF" using the analogy of premalignant conditions.<sup>13</sup> However,
        while indicating the need for such persons to be kept under clinical surveillance it begs
        the question of how to classify subclinical disease and is not a concept which has yet
        found wide acceptance.</span></p>
        <h2><a name="_Toc505740995"></a><a name="_Toc505741647"></a><a
        name="4.&nbsp; A proposed classification for ICD-11"><span
        style="mso-bookmark:_Toc505741647"><span style="mso-bookmark:_Toc505740995"><span
        lang="EN-US">4.<span style="mso-spacerun: yes">&nbsp; </span>A proposed classification for
        ICD-11</span></span></span></a></h2>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><span
        lang="EN-US">All officially recognized medical diagnoses are categorised in the
        International Classification of Diseases (ICD) published by WHO. In the current edition
        (ICD 10), cystic fibrosis is placed in the section devoted to Endocrine, Nutritional and
        Metabolic Diseases, Chapter 4. The classification for cystic fibrosis is subdivided into
        four parts:</span></p>
        <p class="ListBulletmr"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">E84.0<span style="mso-spacerun: yes">&nbsp; </span>CF with pulmonary
        manifestations.</span></p>
        <p class="ListBulletmr"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">E84.1<span style="mso-spacerun: yes">&nbsp; </span>CF with intestinal
        manifestations.</span></p>
        <p class="ListBulletmr"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">E84.8<span style="mso-spacerun: yes">&nbsp; </span>CF with other
        manifestations.</span></p>
        <p class="ListBulletm"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">E84.9<span style="mso-spacerun: yes">&nbsp; </span>CF<span
        style="mso-spacerun: yes">&nbsp; </span>unspecified.<span style="mso-spacerun: yes">
        &nbsp;&nbsp; </span></span></p>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><span
        lang="EN-US">It would be of benefit to patients, families, health care providers, health
        insurers, medico-legal interests and clinicians if this classification could be revised to
        take account of current knowledge and diagnostic problems, and to separately designate
        those related conditions which are not CF, and whose diagnosis has different implications.</span></p>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><span
        lang="EN-US">WHO, ICF(M)A, ECFTN and ECFS therefore convened a joint working group in June
        2000 to produce a new classification suitable for inclusion in the next edition of ICD due
        to be published in 2002 (ICD 11).</span></p>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><span
        lang="EN-US">One possibility was to classify all conditions associated with a CFTR
        mutation as CFTR-Related, but this would exclude patients in whom no mutation can be
        found, and include others in whom the mutation is not of clinical significance and not
        responsible for the clinical features. There are currently more than 900 mutations and
        more than 300 known polymorphisms in the CFTR gene, but even so using CFTR as the
        essential defining criterion would not cover all cases and would be open to
        misinterpretation.</span></p>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">As ICD is a tool for clinicians, it
        was agreed that the diagnostic classification should be made on clinical rather than
        laboratory grounds, while acknowledging the importance of identifying CFTR mutations in
        those persons with clinical conditions such as pancreatitis<sup>14</sup> and atresia of
        the vas deferens<sup>9</sup> where some, but not all cases are CFTR-related.</b> Some of
        these patients may on detailed clinical and laboratory investigation, show minor and
        previously unsuspected features of cystic fibrosis but in others there is no evidence of
        multisystem disease to justify a diagnosis of atypical CF. Other conditions in which some
        cases appear to be aetiologically related to CFTR mutations include allergic
        bronchopulmonary aspergillosis,<sup>15 </sup>disseminated bronchiectasis<sup>16</sup> and
        diffuse panbronchiolitis.<sup>17</sup> There should be appropriate cross-referencing in
        ICD to the same disorders located elsewhere. Where a known mutation is judged to be
        aetiologically related to the disease in an individual the primary diagnostic code should
        be assigned from the section which includes CF. </span></p>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><span
        lang="EN-US">It was also agreed to include a diagnostic category for those infants with
        neonatal hypertrypsinogenemia who are shown to have a single CFTR mutation , the majority
        of whom will be healthy carriers but a few will have an undetected second mutation. There
        is no consensus on the management of these cases but at present there is no code for their
        recording to facilitate future research. </span></p>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><span
        lang="EN-US">The working group agreed that the overall heading for the section should be
        "Cystic Fibrosis and Related Disorders" such as:</span></p>
        <p class="ListBulletmr"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">Classical CF Pancreatic-insufficient (PI).</span></p>
        <p class="ListBulletmr"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">Classical CF Pancreatic-sufficient (PS).</span></p>
        <p class="ListBulletmr"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">Atypical CF.</span></p>
        <p class="ListBulletmr"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">CF other specified.</span></p>
        <p class="ListBulletmr"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">CF not otherwise specified.</span></p>
        <p class="ListBulletmr"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">Isolated obstructive azoospermia</span><a style="mso-footnote-id:ftn1"
        href="#_ftn1" name="_ftnref1" title><span class="MsoFootnoteReference"><span lang="EN-US"
        style="font-family:Symbol;
mso-ascii-font-family:"Times New Roman";mso-hansi-font-family:"Times New Roman";
mso-char-type:symbol;mso-symbol-font-family:Symbol"><span
        style="mso-char-type:
symbol;mso-symbol-font-family:Symbol">*</span></span></span></a><span
        lang="EN-US">.</span></p>
        <p class="ListBulletmr"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">Chronic Pancreatitis*.</span></p>
        <p class="ListBulletmr"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">Allergic bronchopulmonary aspergillosis (ABPA)*.</span></p>
        <p class="ListBulletmr"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">Disseminated bronchiectasis*.</span></p>
        <p class="ListBulletmr"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">Diffuse panbronchiolitis*.</span></p>
        <p class="ListBulletmr"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">Sclerosing Cholangitis*.</span></p>
        <p class="ListBulletm"><span lang="EN-US" style="font-family:
Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US">Neonatal hypertrypsinogenemia.</span></p>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><span
        lang="EN-US">It is likely that this classification will need further revision in the
        future as our knowledge and understanding of these conditions increase.</span></p>
        <h2><a name="_Toc505740996"></a><a name="_Toc505741648"></a><a
        name="5.&nbsp; List of participants"><span style="mso-bookmark:_Toc505741648"><span
        style="mso-bookmark:_Toc505740996"><span lang="EN-US">5.<span style="mso-spacerun: yes">&nbsp;
        </span>List of participants</span></span></span></a></h2>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Accurso, Frank:</b> Children's
        Hospital, 19th Avenue 1056 E - Box B395, CO 802 18 Denver, United States.<span
        style="mso-spacerun: yes">&nbsp; </span>Tel 1-303-8372.522, fax 1-303-8372.924, E-mail
        accurso.frank@tchden.org</span></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Cabeza, Stella:</b> Latin American CF
        Association, Costa Rica 2061, 11500 Montevideo, Uruguay.<span style="mso-spacerun: yes">
        &nbsp; </span>Tel 598-2-6003.842, fax 598-2-2086.849, E-mail smcabeza@medmet.or.uy</span></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Cassiman, Jean-Jacques:</b> European
        CF Thematic Network, KULeuven - Campus Gasthuisberg, Center for Human Genetics, Herestraat
        49, 3000 Leuven, Belgium.<span style="mso-spacerun: yes">&nbsp; </span><br>
        Tel 32-16-34.58.61, fax 32-16-34.59.97, E-mail jean-jacques.cassiman@med.kuleuven.ac.be</span></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Corey, Mary:</b> Hospital for Sick
        Children, University Ave 555. University Wing,<br>
        ON M5G 1X8 Toronto, Canada.<span style="mso-spacerun: yes">&nbsp; </span>Tel
        1-416-8135.750, fax 1-416-8135.292, E-mail mary.corey@sickkids.on.ca</span></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Davidson, A George F:</b>
        International CF(M) Association, University of British Columbia,<br>
        B C's Children's Hospital, Oak Street 4480, BC V6H 3VH Vancouver, Canada.<span
        style="mso-spacerun: yes">&nbsp; </span>Tel <br>
        1-604-8752.142, fax 1-604-8752.349, E-mail </span></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Dequeker, Els: </b>European CF
        Thematic Network,<span style="mso-spacerun: yes">&nbsp; </span>KULeuven - Campus
        Gasthuisberg, Center for Human Genetics, Herestraat 49, 3000 Leuven, Belgium.<span
        style="mso-spacerun:
yes">&nbsp; </span>Tel 32-16-34.58.81, fax <br>
        32-16-34.59.97, E-mail <a href="mailto:els.dequeker@med.kuleuven.ac.be">els.dequeker@med.kuleuven.ac.be</a>
        (<b style="mso-bidi-font-weight:normal">Rapporteur</b>)</span></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Dodge, John:</b> University of Wales
        Swansea, Child Health, Singleton Hospital, SA2 8QA Swansea, United Kingdom.<span
        style="mso-spacerun: yes">&nbsp; </span>Tel 44-1792-205.666, fax 44-1792-285.244, E-mail <a
        href="mailto:j.a.dodge@btinternet.com">j.a.dodge@btinternet.com</a> (<b
        style="mso-bidi-font-weight:normal">Chairman</b>)</span></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Döring, Gerd:</b> European CF
        Society, Hygiene Institute, Department of General and Environmental Hygiene,
        Wilhelmstrasse 31, D-72074 Tübingen, Germany. <br>
        Tel 49-7071-298.20.69, fax 49-7071-293.011, E-mail gerd.doering@uni-tuebingen.de</span></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Heidet, Liliane:</b> International
        CF(M) Association, Chemin de la Montagne 124, 1224 Chene Bougeries, Switzerland.<span
        style="mso-spacerun: yes">&nbsp; </span>Tel 41-22-3489.452, E-mail
        liliane.heidet@bluewin.ch</span></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Heijerman, Harry:</b> Leyenburg
        Hospital, , Leyweg 275, 2545 CH The Hague, The Netherlands.<span style="mso-spacerun: yes">
        &nbsp; </span>Tel 31-70-3592.076, fax 31-70-3592.150, E-mail hgmheij@knmg.nl</span></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Kotsimbos, Tom:</b> Alfred Hospital
        Dept Resp Medicine, Commercial rd Prahran 31-71, Melbourne 3181, Australia. Tel
        61-3-92763844, fax 61-3-92763434, E-mail tom.kotsimbos@med.morsh.edu.au <o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Mastella, Gianni:</b> Azienda
        Ospedaliera di Verona, Cystic Fibrosis Center, Piazzale Stefani 1, 37126 Verona, Italy.<span
        style="mso-spacerun: yes">&nbsp; </span>Tel 39-45-80.72.370, fax 39-45-80.72.042, E-mail
        cfc@linus.univr.it</span></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Morrison, Cathleen:</b> Canadian CF
        Foundation, , Yonge Street 2221 Suite 601, M4S 2B4 Toronto, Ontario, Canada.<span
        style="mso-spacerun: yes">&nbsp; </span>Tel 1-416-4859.149/225, fax 1-416-4850.960, E-mail
        cmorrison@ccff.ca</span></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Pignatti, Pier Franco:</b> European CF
        Thematic Network, University of Verona, Mother and Child - Biology and Genetics, Strada Le
        Grazie 8, 37134 Verona, Italy.<span style="mso-spacerun: yes">&nbsp; </span>Tel
        39-45-58.46.02, fax 39-45-80.98.180, E-mail pignatti@medgen.univr.it</span></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Strandvik, Birgitta:</b> Sahlgrenska
        University Hospital, Department of Pediatrics, 416 85 Göteborg, Sweden. E-mail:
        birgitta.strandvik@pediat.gu.se</span></p>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Tsui, Lap-Chee:</b> International CF
        Consortium, The Hospital for Sick Children, Department of Genetics, University Avenue 555,
        ONT M5G 1X8 Toronto, Canada.<span style="mso-spacerun: yes">&nbsp; </span>Tel
        1-416-8136.015, fax 1-416-8134.931, E-mail lctsui@sickkids.on.ca </span></p>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><b
        style="mso-bidi-font-weight:normal"><span lang="EN-US">List of corresponding members<a
        style="mso-footnote-id:ftn2" href="#_ftn2" name="_ftnref2" title><span
        class="MsoFootnoteReference"><span style="mso-special-character:footnote">[1]</span></span></a></span><span
        lang="FR-CH" style="mso-ansi-language:
FR-CH"><o:p></o:p></span></b></p>
        <p class="MsoNormal" style="line-height:15.0pt;mso-line-height-rule:exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Beall, Robert:</b> US CF Foundation,
        6931 Arlington Road, 2<sup>nd</sup> floor, Bethesda MD 20814 United States. Tel
        1-301-9072541, fax 1-301-9072540, E-mail <span style="color:black"><a
        href="mailto:rjb@cff.org"><span style="color:black">rjb@cff.org</span></a><o:p></o:p></span></span></p>
        <p class="MsoNormal"><b style="mso-bidi-font-weight:normal"><span lang="EN-US">WHO
        Secretariat<o:p></o:p></span></b></p>
        <p class="MsoNormal"
        style="margin-top:6.0pt;line-height:14.0pt;mso-line-height-rule:
exactly"><span
        lang="EN-US"><b style="mso-bidi-font-weight:normal">Boulyjenkov, Victor:</b> World Health
        Organization, Department of Management of NCDs, Human Genetics Programme, 1211 Geneva,
        Switzerland.<span style="mso-spacerun: yes">&nbsp; </span>Tel 41-22-7913.442, <br>
        fax 41-22-7914.769, E-mail boulyjenkovv@who.ch</span></p>
        <h2><a name="_Toc505740997"></a><a name="_Toc505741649"></a><a name="6.&nbsp; References"><span
        style="mso-bookmark:_Toc505741649"><span style="mso-bookmark:_Toc505740997"><span
        lang="EN-US">6.<span style="mso-spacerun: yes">&nbsp; </span>References</span></span></span></a></h2>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">1.<span style="font:7.0pt "Times New Roman"">
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Wilmott RW. Making the diagnosis of cystic fibrosis.
        J Pediatrics 1998, 132, 563-4</span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">2.<span style="font:7.0pt "Times New Roman"">
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Gibson LE, Cooke RE. A test for concentration of
        electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by
        iontopheresis. Pediatrics 1959; 23: 545-9</span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">3.<span style="font:7.0pt "Times New Roman"">
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Legrys VA. Sweat testing for the diagnosis of cystic
        fibrosis: pancreatic considerations <br>
        J Pediatr 1996; 129: 892-7</span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">4.<span style="font:7.0pt "Times New Roman"">
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer
        G, Dean M, et al. Identification of the cystic fibrosis gene; chromosome walking and
        jumping . Science 1989; 245: 1059-65</span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">5.<span style="font:7.0pt "Times New Roman"">
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R,
        Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and
        characterisation of complementary DNA, Science 1989; 245:1066-73</span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">6.<span style="font:7.0pt "Times New Roman"">
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Stern RC. Current concepts: the diagnosis of cystic
        fibrosis. N Engl J Med 1997; <br>
        336:487-91</span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">7.<span style="font:7.0pt "Times New Roman"">
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Chillon M, Casals T, Mercier B, Bassas L, Lissens W,
        Silber S, et al. Mutations in the cystic fibrosis gene in patients with congenital absence
        of the vas deferens. N Eng J Med 1995; 332: 1475-80.</span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">8.<span style="font:7.0pt "Times New Roman"">
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Collin AA, Sawyer SM, Mickle JE, Oates RD, Milunsky
        A, Amos JA. Pulmonary function and clinical observations in men with congenital bilateral
        absence of the vas deferens. Chest 1996; 110:440-5</span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">9.<span style="font:7.0pt "Times New Roman"">
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Stuhrmann NI, Dork T, CFTR gene mutations and male
        infertility, Andrologia 2000; <br>
        32, 71-83</span></p>
        <p class="MsoNormal"
        style="margin-left:17.85pt;text-indent:-17.85pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">10.<span style="font:7.0pt "Times New Roman"">&nbsp; </span>Lester
        LA, Kraut J, Lloyd-Still J, Karrison T, Mott C, Billstrand C, Lemke A, Ober C, Delta F508
        genotype does not predict disease severity in an ethnically diverse cystic fibrosis
        population. Pediatrics 1994; 93(1), 114-118<i style="mso-bidi-font-style:normal"><o:p></o:p></i></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">11.<span style="font:7.0pt "Times New Roman"">&nbsp; </span>Zielenski
        J, Corey M, Rozmahel R, Markiewicz D, Aznarez I, Casals T, Larriba S, Mercier B, Cutting
        GR, Krebsova A, Macek M Jr, Langfelder-Schwind E, Marshall BC, DeCelie-Germana J,
        Claustres M, Palacio A, Bal J, Nowakowska A, Ferec C, Estivill X, Durie P, Tsui LC,
        Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13
        Nat Genet 2000; 22, 128-9<i style="mso-bidi-font-style:normal"><o:p></i></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">12.<span style="font:7.0pt "Times New Roman"">&nbsp; </span>Rosenstein
        BJ, Cutting GR, Cystic fibrosis Foundation Consensus Panel. The diagnosis of cystic
        fibrosis: a consensus statement. J Pediatr 1998;132, 589-595</span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">13.<span style="font:7.0pt "Times New Roman"">&nbsp; </span>Bush A,
        Wallis C, Time to think again - cystic fibrosis, like cancer, is not an "all or
        none" disease. Pediatric Pulmonology 2000; 30, 139-144</span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">14.<span style="font:7.0pt "Times New Roman"">&nbsp; </span>Sharer
        N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J, Mutations of the cystic
        fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998; 339, 645-652</span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">15.<span style="font:7.0pt "Times New Roman"">&nbsp; </span>Weiner
        Miller P, Hamosh A, Macek M Jr, Greenberger PA, MacLean J, Walden SM, Slavin RG, Cutting
        GR, Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic
        bronchopulmonary aspergillosis Am J Hum Genet 1996; <br>
        59, 45-51</span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">16.<span style="font:7.0pt "Times New Roman"">&nbsp; </span>Pignatti
        PF, Bombieri C, Marigo C, Benetazzo MG, Luisetti M, Increased incidence of cystic fibrosis
        gene mutations in adults with disseminated bronchiectasis. Hum Mol Genet 1995; 4, 635-639<i
        style="mso-bidi-font-style:
normal"><o:p></o:p></i></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;line-height:
15.0pt;mso-line-height-rule:exactly;mso-list:l5 level1 lfo5;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US">17.<span style="font:7.0pt "Times New Roman"">&nbsp; </span>Cystic
        Fibrosis Mutation Database, Hospital for Sick Children, Toronto, <a
        href="http://www.genet.sickkids.on.ca/">www.genet.sickkids.on.ca</a></span></p>
        <hr align="left" size="1" width="33%">
        <p><a style="mso-footnote-id:ftn1" href="#_ftnref1" name="_ftn1" title><span
        class="MsoFootnoteReference"><span lang="EN-US"
        style="font-family:Symbol;mso-ascii-font-family:"Times New Roman";mso-hansi-font-family:
"Times New Roman";mso-char-type:symbol;mso-symbol-font-family:Symbol"><span
        style="mso-char-type:symbol;mso-symbol-font-family:Symbol">*</span></span></span></a><span
        lang="EN-US"> At least one CFTR mutation identified</span></p>
        <p><span lang="EN-US"><a style="mso-footnote-id:ftn2" href="#_ftnref2" name="_ftn2" title><span
        class="MsoFootnoteReference"><span style="mso-special-character:footnote">[1]</span></span></a>
        Unable to be present, corresponding members</span></td>
      </tr>
</TBODY>
      <tr>
        <td colSpan="2" vAlign="top" width="654" height="0"><hr>
        <h5 align="center">| <a href="/">WHO Home</a> |<br>
        | <a href="../asthma/index.htm">Asthma</a> | <a href="../cancer/index.htm">Cancer</a> | <a
        href="../cvd/index.htm">Cardiovascular diseases</a> | <a href="../dia/index.htm">Diabetes</a>
        | <a href="index.htm">Human genetics</a> | <a href="../orh/index.htm">Oral health</a> | <a
        href="http://www5.who.int/tobacco/">Tobacco use</a> | <a href="../noma/index.htm">Noma</a>
        |<br>
        </h5>
        <h5 align="left"><font size="2">Contact us: <a href="mailto:ncdinfo@who.int">ncdinfo@who.int</a>
        .<br>
        Copyright </font><font size="1"><a class="Asmall"
        href="/home/copyright/index.en.html">© WHO/OMS, 2001</a> </font></h5>
        </td>
      </tr>
    </table>
    </center></div></td>
  </tr>
</TBODY>
</table>
<p>&nbsp;</p>
</body>
</html>

